Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis

Parasite Immunology

Volumn 31, Issue 8, 2009, Pages 423-431

  Silveira, F T ^a,b   Lainson, R ^a   De Castro Gomes, C M ^c   Laurenti, M D ^c   Corbett, C E P ^c  

^a INSTITUTO EVANDRO CHAGAS   (Brazil)

^b FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

American cutaneous leishmaniasis; Immunopathogenic competences; L. (L.) amazonensis; Leishmania (V.) braziliensis

Indexed keywords

CLONAL ANERGY; DENDRITIC CELL; DESENSITIZATION; HOST PARASITE INTERACTION; HUMAN; HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; LANGERHANS CELL; LEISHMANIA BRAZILIENSIS; MACROPHAGE; NONHUMAN; PARASITE; PRIORITY JOURNAL; PROTOZOAL INFECTION; PSYCHODIDAE; REVIEW; SKIN LEISHMANIASIS; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ANIMALS; CELL DIVISION; HUMANS; LEISHMANIA; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, CUTANEOUS; SKIN; SPECIES SPECIFICITY; TH1 CELLS; TH2 CELLS; VIRULENCE;

LEISHMANIA AMAZONENSIS; LEISHMANIA BRAZILIENSIS;

EID: 68249162071     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2009.01116.x     Document Type: Review

References (66)

1. Lainson R Shaw JJ. New World leishmaniasis - the neotropical Leishmania species. In Cox FEG, Kreier JP Wakelin D (eds Topley & Wilson's Microbiology and Microbial Infections, 9th edn. London, Parasitology, Arnold, Vol. 5, 1998 : 242 266.
2. Lainson R Shaw JJ. Leishmaniasis in the New World. In Collier L, Balows A Sussman M (eds Topley & Wilson's Microbiology and Microbial Infections, 10th edn. London, Parasitology, Arnold, Vol. 5, 2005 : 313 349.
3. Silveira FT, Lainson R, De Brito AC, et al. Leishmaniose tegumentar americana. In Leão RNG (ed Doenças Infecciosas e Parasitárias: Enfoque Amazônico, Belém, PA, CEJUP, 1997 : 619 630.
4. Silveira FT, Lainson R Corbett CEP. Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil. Mem Inst Oswaldo Cruz 2004 99 : 239 251.
5. Silveira FT, Lainson R Corbett CEP. Further observations on clinical, histopathological and immunological features of borderline disseminated cutaneous leishmaniasis caused by Leishmania (Leishmania) amazonensis. Mem Inst Oswaldo Cruz 2005 100 : 525 534.
6. Lainson R Shaw JJ. Evolution, classification and geographical distribution. In Peters W Killick-Kendrick R (eds The Leishmaniases in Biology and Medicine. London, Academic Press, Vol. 1, 1987 : 1 120.
7. Peters NC, Egen JG, Secundino N, et al. In vivo imaging reveals an essential role for neutrophil in leishmaniasis transmitted by sand flies. Science 2008 321 : 970 974.
8. John B Hunter CA. Neutrophil soldiers or Trojan horses? Science 2008 321 : 917 918.
9. Laskay T, Van Zandbergem G Solbach W. Neutrophil granulocytes as host cells and transport vehicles for intracellular pathogens: Apoptosis as infection-promoting factor. Immunobiology 2008 213 : 183 191.
10. Sacks DL Perkins PV. Identification of an infective stage of Leishmania promastigotes. Science 1984 223 : 1417.
11. Sacks DL da Silva RP. The generation of infective stage Leishmania major promastigotes is associated with the cell-surface expression and release of a developmentally regulated glycolipid. J Immunol 1987 139 : 3099.
12. Vannier-Santos MA, Martiny A De Souza W. Cell biology of Leishmania spp.: invading and evading. Curr Pharm Des 2002 8 : 297 318.
13. Petzl-Erler ML, Belich MP Queiroz-Telles F. Association of mucosal leishmaniasis with HLA. Hum Immunol 1991 32 : 254 260.
14. Lara ML, Layrisse Z, Scorsa JV, et al. Immunogenetics of human American cutaneous leishmaniasis. Study of HLA haplotypes in 24 families from Venezuela. Hum Immunol 1991 30 : 129 135.
15. Blackwell JM. Tumour necrosis factor alpha and mucocutaneous leishmaniasis. Parasitol Today 1999 15 : 73 76.
16. Castellucci L, Menezes E, Oliveira J, et al. IL6-174 G/C promoter polymorphism influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil. J Inf Dis 2007 194 : 519 527.
17. Campos MB, Gomes CMC, De Souza AAA, Lainson R, Corbett CEP Silveira FT. In vitro infectivity of species of Leishmania (Viannia) responsible for American cutaneous leishmaniasis. Parasitol Res 2008 108 : 771 776.
18. Silveira FT, Lainson R, Gomes CMC, Laurenti MD Corbett CEP. Reviewing the role of the dendritic Langerhans cell in the immunopathogenesis of American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg 2008 102 : 1075 1080.
19. Garg H, Trudel N Trembley MJ. Consequences of the natural propensity of Leishmania and HIV-1 to target dendritic cells. Trends Parasitol 2007 23 : 317 324.
20. Soong L. Modulation of dendritic cell function by Leishmania parasites. J Immunol 2008 180 : 4355 4360.
21. Von Stebut E, Belkaid Y, Jacob T, Sacks DL Udey MC. Uptake of Leishmania major amastigotes results in activation and IL-12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J Exp Med 1998 188 : 1547 1552.
22. + dendritic cells is sufficient for control of Leishmania major. J Exp Med 2004 199 : 725 730.
23. + subsets during murine Leishmania major infection. Res Immunol 1991 142 : 28 32.
24. Sacks D Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2002 2 : 845 858.
25. Weinberg JB. Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review. Mol Med 1998 4 : 557 591.
26. Bogdan C, Donhauser N, Döring R, Röllinghoff M, Diefenbach A Rittig MG. Fibroblasts as host cells in latent leishmaniosis. J Exp Med 2000 191 : 2121 2129.
27. Moll H, Flohé S Rollinghoff M. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T-cell immune response. Eur J Immunol 1995 25 : 693 699.
28. Girolomoni G, Caux C, Lebecque S, Dezutter-Dambuyant C Ricciardi-Castagnoli P. Langerhans cells: still a fundamental paradigm for studying the immunobiology of dendritic cells. Trends Immunol 2002 23 : 6 8.
29. Ritter U, Meissner A, Scheidig C Körner H. CD8α- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis. Eur J Immunol 2004 34 : 1542 1550.
30. Kaplan DH, Jenison MC, Saeland S, Shlomchik WD Shlomchik MJ. Epidermal Langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 2005 23 : 611 620.
31. Ritter U Osterloh A. A new view on cutaneous dendritic cell subsets in experimental leishmaniasis. Med Microbiol Immunol 2007 196 : 51 59.
32. Carvalho EM, Correia-Filho D, Baccelar O, Lessa H Rocha H. Characterization of the immune response in subjects with self healing cutaneous leishmaniasis. Am J Trop Med Hyg 1995 53 : 273 277.
33. Da-Cruz A, De Oliveira MP, De-Luca PM, Mendonça SC Coutinho SG. Tumor necrosis factor-alpha in human American tegumentary leishmaniasis. Mem Inst Oswaldo Cruz 1996 91 : 225 229.
34. Bacellar O, Lessa H, Schriefer A, et al. Up-regulation of Th1-type responses in mucosal leishmaniasis patients. Infect Immun 2002 70 : 6734 6740.
35. Petersen EA, Neva FA, Oster CN Diaz HB. Specific inhibition of lymphocyte proliferation response by adherent suppressor cells in diffuse cutaneous leishmaniasis. N Engl J Med 1982 306 : 387 391.
36. Barral A, Costa JML, Bittencourt AL, Barral-Neto M Carvalho EM. Polar and subpolar diffuse cutaneous leishmaniasis in Brazil: clinical and immunopathologic aspects. Int J Dermatol 1995 34 : 474 479.
37. Costa JML, Marsden PD, Llanos-Cuentas EA, et al. Disseminated cutaneous leishmaniasis in a field clinic in Bahia, Brazil: a report of eight cases. J Trop Med Hyg 1986 89 : 319 321.
38. Carvalho EM, Barral A, Costa JML, Bittencourt A Marsden PD. Clinical and immunopathological aspects of disseminated cutaneous leishmaniasis. Acta Trop 1994 56 : 315 325.
39. Turetz ML, Machado PR, Ko AI, et al. Disseminated leishmaniasis: a new and emerging form of leishmaniasis observed in northeastern Brazil. J Infect Dis 2002 186 : 1829 1834.
40. Ribeiro-de-Jesus A, Almeida RP, Lessa H, Baccelar O Carvalho EM. Cytokine profile and pathology in human leishmaniasis. Braz J Med Biol Res 1998 31 : 143 148.
41. Barral-Netto M, Brodskyn C, Carvalho EM Barral A. Braz J Med Biol Res 1998 31 : 149 155.
42. + T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of regulatory T cells. J Infect Dis 2006 193 : 1313 1322.
43. Cáceres-Dittmar G, Tapia FJ, Sanchez MA, et al. Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction. Clin Exp Immunol 1993 91 : 500 505.
44. Pirmez C, Yamamura M, Uyemura K, Paes-Oliveira M, Conceição- Silva F Modlin RL. Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest 1993 91 : 1390 1395.
45. Silveira FT, Lainson R, Shaw JJ, De Souza AAA, Ishikawa EA Braga RR. Cutaneous leishmaniasis due to Leishmania (Leishmania) amazonensis in Amazonian Brazil, and the significance of a negative Montenegro skin-test in human infections. Trans R Soc Trop Med Hyg 1991 85 : 735 738.
46. Silveira FT, Blackwell JM, Ishikawa EA, et al. T-cell responses to crude and defined leishmanial antigens in patients from the lower Amazon region of Brazil infected with different species of Leishmania of the subgenera Leishmania and Viannia. Parasite Immunol 1998 20 : 19 26.
47. Lemos de Souza V, Ascenção Souza J, Correia Silva TM, Sampaio Tavares Veras P Rodrigues de Freitas LA. Different Leishmania species determine distinct profiles of immune and histopathological responses in CBA mice. Microbes Infect 2000 2 : 1807 1815.
48. Guimarães ET, Santos LA, Ribeiro dos Santos R, Teixeira MM, Dos Santos WL Soares MB. Role of interluekin-4 and prostagladin E2 in Leishmania amazonensis infection of BALB/c mice. Mic Infect 2006 8 : 1219 1226.
49. Martinez-Arends A, Tapia FJ, Caceres-Dittmar G, Mosca W, Valecil L Convit J. Immunocytochemical characterization of immune cells in lesions of American cutaneous leishmaniasis using novel T cell markers. Acta Trop 1991 49 : 271 280.
50. Faria DR, Gollob KJ, Barbosa J Jr., et al. Decrease in situ expression of interleukin-10 receptor is correlated with the exacerbated inflammatory and cytotoxic responses observed in mucosal leishmaniasis. Infect Immun 2005 73 : 7853 7859.
51. Bonfim G, Nascimento C, Costa JML, Carvalho EM, Barral-Neto M Barral A. Variation of cytokine patterns related to therapeutic response in diffuse cutaneous leishmaniasis. Exp Parasitol 1996 84 : 188 194.
52. Peters N Sacks D. Immune privilege in sites of chronic infection: Leishmania and regulatory T cells. Immunol Rev 2006 213 : 159 179.
53. Convit J, Pinardi ME Rondon AJ. Diffuse cutaneous leishmaniasis: a disease due to an immunological defect of the host. Trans R Soc Trop Med Hyg 1972 66 : 603 610.
54. Barral-Netto M, Cardoso SA Barral A. Different patterns of disease in two inbred mouse strains infected with a clone of Leishmania mexicana amazonensis. Acta Trop 1987 44 : 5 11.
55. Barral A, Pedral-Sampaio D, Grimaldi G Jr., et al. Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Ame J Trop Med Hyg 1991 44 : 536 546.
56. Viana da Costa A, Huerre M, Delacre M, Aurialt C, Correia Costa JM Verwaerde C. IL-10 leads to a high parasite persistence in a resistant mouse model of Leishmania major infection. Parasitol Int 2002 51 : 367 379.
57. Villaseñor-Cardoso MI, Salaiza N, Delgado J, Gutierrez-Kobeh L, Perez-Torrez A Becker I. Mast cells are activated by Leishmania mexicana LPG and regulate disease outcome depending on the genetic background of the host. Parasite Immunol 2008 30 : epub ahead of print.
58. Trujillo CM, Robledo SM, Franco JL, Velez ID, Erb KJ Patinõ PJ. Endemically exposed asymptomatic individuals show no increase in the specific Leishmania (Viannia) panamensis-Th1 immune response in comparison to patients with localized cutaneous leishmaniasis. Parasite Immunol 2002 24 : 455 462.
59. Delgado G, Parra-López CA, Vargas LE, et al. Characterizing cellular immune response to kinetoplastid membrane protein-11 (KMP-11) during Leishmania (Viannia) panamensis infection using dendritic cells (DCs) as antigen presenting cells (APCs). Parasite Immunol 2003 25 : 199 209.
60. Calvopina M, Gomez EA, Sindermann H, Cooper PJ Hashiguchi Y. Relapse of New World diffuse cutaneous leishmaniasis caused by Leishmania (Leishmania) mexicana after miltefosine treatment. Am J Trop Med Hyg 2006 75 : 1074 1077.
61. Hsu AC Scott P. Leishmania mexicana infection induces impaired lymph node expansion and Th1 cell differentiation despite normal T cell proliferation. J Immunol 2007 179 : 8200 8207.
62. Xavier MB, Silveira FT, Demachki S, Ferrreira MMR Nascimento JL. American tegumentary leishmaniasis: A quantitative analysis of Langerhans cells presents important differences between L. (L.) amazonensis and Viannia subgenus. Acta Trop 2005 95 : 67 73.
63. Carvalho LP, Pearce EJ Scott P. Functional dichotomy of dendritic cells following interaction with Leishmania (V.) braziliensis: Infected cells produce high levels of TNF-α, whereas bystander dendritic cells are activated to promote T cell responses. J Immunol 2008 181 : 6473 6480.
64. Vargas-Inchaustegui DA, Xin L Soong L. Leishmania braziliensis infection induces dendritic cell activation, ISG15 transcription, and the generation of protective immune responses. J Immunol 2008 180 : 7537 7545.
65. Favali C, Tavares N, Clarêncio J, Barral A, Barral-Neto M Brodskyn C. Leishmania amazonensis infection impairs differentiation and function of human dendritic cells. J Leuk Biol 2007 82 : 1 6.
66. + T-cell functions during Leishmania amazonensis infection. Infect Immun 2008 76 : 161 169.